Rojas Out for 2026: Phillies Depth Chart Already Settled, But Surgery Timeline Matters for Fantasy and Futures

Philadelphia's Johan Rojas will undergo internal brace surgery to repair a torn ulnar collateral ligament in his right elbow, the club announced Wednesday. The procedure is scheduled within the next two weeks, formally ending his 2026 season and locking him out of any postseason participation. The timing compounds an already difficult spring for the 25-year-old: Rojas began the season serving an 80-game suspension after testing positive for Boldenone, a banned anabolic steroid, under MLB's Joint Drug Prevention and Treatment Program. The suspension opened in early April and was set to run through mid-June. The UCL injury arrived during his ramp-up activities designed to prepare him for a potential late-season return—a window that no longer exists.

The injury itself is secondary noise in Rojas's 2026 narrative. His suspension already removed him from Philadelphia's working roster for two-and-a-half months. What matters for the Phillies is that his absence erases the only realistic candidate to challenge the current outfield hierarchy. Last season, Rojas appeared in 71 games with a .224 batting average and .569 OPS, numbers that made him marginal even as a reserve. The front office had penciled him in as a potential fifth outfielder this year—insurance, not solution. Crawford, Marsh, and García have occupied the three spots all season, with the team cycling minor-league depth when injuries or rest days demanded it. Rojas's elbow injury simply removes one name from a list that was already operating without him.

The surgery timeline matters more than the diagnosis. The Phillies are targeting an internal brace procedure within two weeks from Wednesday—placing the surgery roughly by late June. That timeline suggests a 4-6 month recovery window, positioning Rojas for participation in 2027 Spring Training by late February or early March. For betting and roster construction purposes, Rojas is effectively a 2027 asset. The suspension and injury have compressed his 2026 presence into a non-event. From a team-construction standpoint, Philadelphia has already allocated those roster spots and playing time to proven commodities. The depth-chart implications are negligible.

The betting angle here tracks to what the Phillies' outfield depth chart now guarantees: the absence of an internal challenger to the three established starters. Phillies team totals and run-production props should be evaluated with the understanding that Philadelphia's offensive personnel is now crystallized for the remainder of 2026. No late-season recalibration is coming from the farm or from a returning prospect. The Philly bench remains constructed around role players and emergency call-ups—not fresh position talent. For over-heavy bettors leaning on Phillies postseason scenarios that depend on outfield depth holding up under injury, the surgery confirms that buffer has contracted. Any Phillies futures tied to an unexpected outfield breakout or a hidden depth asset punching above weight become harder bets to justify. The team's ceiling is now defined by the nine position players already in place.